New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2013
08:10 EDTSNTISenesco to provide update on Phase 1b/2a trial at hematology meeting
Senesco Technologies announced that it will make two presentations on its gene regulation technology for blood-borne cancer care at the 55th American Society of Hematology Annual Meeting and Exposition to be held from December 7-10. The abstracts are available on the ASH website, Senesco said.
News For SNTI From The Last 14 Days
Check below for free stories on SNTI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
08:15 EDTSNTISenesco Technologies to change name to Sevion Therapeutics
Senesco Technologies announced a corporate rebranding under which the company will change its name to Sevion Therapeutics, Inc. The company will continue to trade as SNTI until a new ticker symbol is obtained. The rebranding and new corporate identity are first steps in fulfilling the company’s goal of becoming a preeminent, next-generation biologics company with best- and first-in-class product candidates and technologies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use